Summary of Study ST003104

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001927. The data can be accessed directly via it's Project DOI: 10.21228/M8N42X This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST003104
Study TitleMetabolomics studies on human cardiac samples
Study SummaryTargeted metabolomics was performed to measure polar metabolites in both positive and negative ionization mode on left ventricular tissue acquired from pre-mortem healthy donor hearts as classified by formal pathological examination and stored at the Sydney Heart Bank. The minimum number of observations for young (age ≤ 25 years) and old (age ≥ 50 years) cohorts using liquid chromatography-tandem mass spectrometry (LC-MS/MS).
Institute
University of Sydney
DepartmentMedicine and Health
Last NameKoay
First NameYen Chin
AddressCharles Perkin Centre
Emailyen.koay@sydney.edu.au
Phone+61486275851
Submit Date2023-09-10
Num Groups2
Total Subjects25
Num Males15
Num Females10
Raw Data AvailableYes
Raw Data File Type(s)mzML
Analysis Type DetailAPI
Release Date2024-03-11
Release Version1
Yen Chin Koay Yen Chin Koay
https://dx.doi.org/10.21228/M8N42X
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR001927
Project DOI:doi: 10.21228/M8N42X
Project Title:The Human Cardiac “Age-OME”: Age-specific changes in myocardial molecular expression
Project Type:MS analysis
Project Summary:A substantial proportion of the World’s population is ageing. One of the most significant risk factors for heart disease is ageing. However, we do not understand how the human heart changes with age. Taking advantage of a unique set of pre-mortem, cryopreserved, non-diseased human hearts, we performed multi-omic analyses (transcriptomics, proteomics, metabolomics and lipidomics), coupled with biological computational modelling in younger (<25 years old) and older hearts (>50years old) to describe the molecular landscape of human cardiac ageing. In older hearts, we observed a downregulation of proteins involved in calcium signalling and of the contractile apparatus itself. In addition, we found a potential counteractive upregulation of central carbon generation of fuel, upregulation of glycolysis and increases in long-chain fatty acids. This is the first molecular data set of normal human cardiac ageing, which may have important implications for the development of age-related heart disease.
Institute:University of Sydney
Department:School of Medical Sciences
Laboratory:Cardiometabolic Medicine
Last Name:Koay
First Name:Yen Chin
Address:The Hub, Charles Perkins Centre, D17, The University of Sydney, NSW, 2006
Email:yen.koay@sydney.edu.au
Phone:+61486275851

Subject:

Subject ID:SU003219
Subject Type:Human
Subject Species:Homo sapiens
Taxonomy ID:9606
Age Or Age Range:Young donors (aged 25 years or younger) and older donors (aged 50 years or older).
Gender:Male and female

Factors:

Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)

mb_sample_id local_sample_id Sample source Group Sex
SA333595old_6heart tissue Old Female
SA333596old_5heart tissue Old Female
SA333597old_7heart tissue Old Female
SA333598old_11heart tissue Old Female
SA333599old_13heart tissue Old Female
SA333600old_3heart tissue Old Female
SA333601old_1heart tissue Old Female
SA333602old_8heart tissue Old Male
SA333603old_2heart tissue Old Male
SA333604old_9heart tissue Old Male
SA333605old_10heart tissue Old Male
SA333606old_12heart tissue Old Male
SA333607old_4heart tissue Old Male
SA333608young_7heart tissue Young Female
SA333609young_10heart tissue Young Female
SA333610young_12heart tissue Young Female
SA333611young_9heart tissue Young Male
SA333612young_3heart tissue Young Male
SA333613young_2heart tissue Young Male
SA333614young_4heart tissue Young Male
SA333615young_11heart tissue Young Male
SA333616young_5heart tissue Young Male
SA333617young_1heart tissue Young Male
SA333618young_8heart tissue Young Male
SA333619young_6heart tissue Young Male
Showing results 1 to 25 of 25

Collection:

Collection ID:CO003212
Collection Summary:Control donor hearts that were considered suitable for transplantation but ultimately not used due to factors such as transport issues, immune mismatches, and size discrepancies between donor and recipient, rather than being post-mortem specimens were collected in this study. These hearts came from individuals who died of non-cardiac reasons and had no risk factors for heart disease, including having a BMI under 30. Following a thorough pathological review, these hearts were confirmed to be structurally normal through histological evaluation. Left ventricular (LV) samples were taken directly in the operating room, immediately snap-frozen in liquid nitrogen at -196°C, and then stored at the Sydney Heart Bank at the University of Sydney, at temperatures ranging from -170 to -180°C. This collection process received the ethical green light from the University of Sydney's Ethics Committee (USYD # 2021/122).
Sample Type:Heart
Storage Conditions:Described in summary

Treatment:

Treatment ID:TR003228
Treatment Summary:The samples detailed in this study did not undergo any treatment.

Sample Preparation:

Sampleprep ID:SP003225
Sampleprep Summary:Briefly, approximately 50 mg of ground heart tissue was weighed into 2 mL Eppendorf tube and subjected to a two-phase extraction protocol involving tissue, ice-cold extraction medium (methanol:water, and chloroform). Samples were then centrifuged at 14 300 rpm at 4 °C for 25 min. The aqueous layer was transferred into a new microfuge tube, concentrated in the Speed-Vac SPD120 (Thermo Fisher Scientific) and dried under nitrogen stream, followed by reconstitution in the acetonitrile/methanol/formic acid (75:25:0.2; v/v/v, HPLC grade; Thermo Fisher Scientific) for the HILIC analysis, and acetonitrile/methanol (25:25; v/v/v, HPLC grade) for the AMIDE analysis.

Combined analysis:

Analysis ID AN005082 AN005083
Analysis type MS MS
Chromatography type HILIC HILIC
Chromatography system Agilent 1260 Agilent 1260
Column Waters Atlantis T3 (150 x 4.6mm,5um) Waters XBridge BEH Amide (100 x 2.1mm,2.5um)
MS Type API API
MS instrument type Triple quadrupole Triple quadrupole
MS instrument name ABI Sciex 5500 QTrap ABI Sciex 5500 QTrap
Ion Mode POSITIVE NEGATIVE
Units abundance abundance

Chromatography:

Chromatography ID:CH003839
Chromatography Summary:Chromatographic method to detect analytes such as amino acids, endocannabinoids, fatty acid β-oxidation intermediates, gut-derived metabolites, nucleotides, neurotransmitters, cofactors and vitamins.
Instrument Name:Agilent 1260
Column Name:Waters Atlantis T3 (150 x 4.6mm,5um)
Column Temperature:40
Flow Gradient:The LC gradient program begins with an initial condition of 5% solvent A and 95% solvent B, with a flow rate of 0.25 mL/min, which is held for 0.5 minutes to establish system equilibration. The gradient then proceeds as follows: at 6 minutes, the mobile phase composition shifts to 60% solvent A and 40% solvent B for 3minutes; at 10 minutes, it changes back to 5% solvent A and 95% solvent B; at 11 minutes, the flow rate increases to 0.4 mL/min while maintaining a composition of 5% solvent A and 95% solvent B for a duration of 12.5 minutes; and at 24.5 minutes, the flow rate decreases back to 0.25 mL/min. The final condition is maintained for 1 minutes to ensure stability before subsequent analyses.
Flow Rate:0.250 – 0.400 mL/min
Solvent A:100% water; 0.1% formic acid; 10 mM ammonium formate (pH ~2.5)
Solvent B:100% acetonitrile; 0.1% formic acid
Chromatography Type:HILIC
  
Chromatography ID:CH003840
Chromatography Summary:Chromatographic method to detect analytes including amino acids, nucleotides, nucleosides, nucleotide triphosphates, high energy intermediates, organic acids, TCA cycle intermediates, bile acids and vitamins.
Instrument Name:Agilent 1260
Column Name:Waters XBridge BEH Amide (100 x 2.1mm,2.5um)
Column Temperature:40
Flow Gradient:The LC gradient program is initialized with an initial mobile phase composition of 15% solvent A and 85% solvent B at a flow rate of 0.25 mL/min. Over the course of 8 minutes, the mobile phase composition undergoes a transition to 65% solvent A and 35% solvent B. Subsequently, at 8 minutes, the composition shifts to 98% solvent A and 2% solvent B, maintained for 1 minute. The mobile phase reverts back to the initial composition of 15% solvent A and 85% solvent B at 10 minutes. At 12.5 minutes, the flow rate is increased to 0.5 mL/min, while maintaining a constant mobile phase composition of 15% solvent A and 85% solvent B for a period of 2.5 minutes. Finally, at 15 minutes, the flow rate is reduced back to 0.25 mL/min. To ensure system stability, the final condition is maintained for 1 minute prior to subsequent analyses.
Flow Rate:0.250 – 0.400 mL/min
Solvent A:95% acetonitrile/5%; water 20mM ammonium acetate; 20mM ammonium hydroxide (pH 9.0)
Solvent B:100% acetonitrile
Chromatography Type:HILIC

MS:

MS ID:MS004820
Analysis ID:AN005082
Instrument Name:ABI Sciex 5500 QTrap
Instrument Type:Triple quadrupole
MS Type:API
MS Comments:Targeted metabolite profiling was performed using MS multiple reaction-monitoring transitions. Multiple Reaction Monitoring (MRM) Q1/Q3 peak integration of the raw data files (Analyst software, v.1.6.2; ABSciex) was performed using software MultiQuant 3.0 (ABSciex).
Ion Mode:POSITIVE
  
MS ID:MS004821
Analysis ID:AN005083
Instrument Name:ABI Sciex 5500 QTrap
Instrument Type:Triple quadrupole
MS Type:API
MS Comments:Targeted metabolite profiling was performed using MS multiple reaction-monitoring transitions. Multiple Reaction Monitoring (MRM) Q1/Q3 peak integration of the raw data files (Analyst software, v.1.6.2; ABSciex) was performed using software MultiQuant 3.0 (ABSciex).
Ion Mode:NEGATIVE
  logo